Christopher Brand

1.1k total citations
18 papers, 473 citations indexed

About

Christopher Brand is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Christopher Brand has authored 18 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 10 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Epidemiology. Recurrent topics in Christopher Brand's work include Retinal Diseases and Treatments (13 papers), Retinal Imaging and Analysis (10 papers) and Retinal and Optic Conditions (7 papers). Christopher Brand is often cited by papers focused on Retinal Diseases and Treatments (13 papers), Retinal Imaging and Analysis (10 papers) and Retinal and Optic Conditions (7 papers). Christopher Brand collaborates with scholars based in United Kingdom, United States and Spain. Christopher Brand's co-authors include Carolyn Czoski‐Murray, Nick Bansback, Mireia Espallargues, Lindsey Hughes, John Brazier, Jill Carlton, Martin McKibbin, Louise Downey, David Squirrell and Clare Bailey and has published in prestigious journals such as Ophthalmology, Investigative Ophthalmology & Visual Science and British Journal of Ophthalmology.

In The Last Decade

Christopher Brand

18 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Brand United Kingdom 10 352 238 90 73 61 18 473
Benjamin K. Young United States 13 277 0.8× 184 0.8× 15 0.2× 53 0.7× 90 1.5× 66 435
Mark Greve Canada 17 673 1.9× 593 2.5× 22 0.2× 67 0.9× 70 1.1× 57 834
Tomasz P. Stryjewski United States 11 203 0.6× 168 0.7× 12 0.1× 18 0.2× 64 1.0× 33 352
Cindy X. Cai United States 11 233 0.7× 116 0.5× 10 0.1× 30 0.4× 120 2.0× 37 334
Oliver Job Switzerland 8 185 0.5× 186 0.8× 4 0.0× 81 1.1× 22 0.4× 22 300
Nakhleh Abu‐Yaghi Jordan 12 266 0.8× 107 0.4× 4 0.0× 26 0.4× 58 1.0× 27 336
Xinxiao Gao China 10 435 1.2× 355 1.5× 11 0.1× 32 0.4× 44 0.7× 29 492
Stanford Taylor United States 8 172 0.5× 92 0.4× 29 0.3× 10 0.1× 16 0.3× 12 309
Mildred M.G. Olivier United States 10 357 1.0× 233 1.0× 8 0.1× 22 0.3× 27 0.4× 16 409
Xuan Shi China 10 126 0.4× 88 0.4× 6 0.1× 16 0.2× 70 1.1× 28 325

Countries citing papers authored by Christopher Brand

Since Specialization
Citations

This map shows the geographic impact of Christopher Brand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Brand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Brand more than expected).

Fields of papers citing papers by Christopher Brand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Brand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Brand. The network helps show where Christopher Brand may publish in the future.

Co-authorship network of co-authors of Christopher Brand

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Brand. A scholar is included among the top collaborators of Christopher Brand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Brand. Christopher Brand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Soliman, Mohamed Kamel, Javier Zarranz‐Ventura, Usha Chakravarthy, et al.. (2023). UNITED KINGDOM DATABASE STUDY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) FOR MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION. Retina. 43(4). 679–687. 5 indexed citations
2.
Chakravarthy, Usha, Clare Bailey, Peter H. Scanlon, et al.. (2020). Progression from Early/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors. Ophthalmology Retina. 4(7). 662–672. 43 indexed citations
3.
Chakravarthy, Usha, Clare Bailey, Peter H. Scanlon, et al.. (2019). Direct Ophthalmic Healthcare Resource Use among Patients with Geographic Atrophy in a Large Cohort from the United Kingdom. Ophthalmology Retina. 3(11). 920–926. 6 indexed citations
4.
Chakravarthy, Usha, Clare Bailey, Robert L. Johnston, et al.. (2018). Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration. Ophthalmology. 125(6). 842–849. 84 indexed citations
5.
Brand, Christopher, et al.. (2018). IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration. Eye. 32(8). 1345–1352. 5 indexed citations
6.
Lee, Aaron, Cecilia S. Lee, Catherine Egan, et al.. (2017). UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice. British Journal of Ophthalmology. 101(12). 1683–1688. 35 indexed citations
7.
Lee, Cecilia S., Catherine Egan, Clare Bailey, et al.. (2017). VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED. Retina. 38(5). 951–956. 10 indexed citations
8.
Brand, Christopher, et al.. (2016). One-year outcomes with ranibizumab in treatment naïve patients with neovascular age-related macular degeneration: an interim analysis from the LUMINOUS™ study. Investigative Ophthalmology & Visual Science. 57(12). 515–515. 1 indexed citations
9.
Brand, Christopher. (2015). Book Review: Race and Sport: Evolution and Racial Differences in Sporting Ability. Mankind Quarterly. 56(2). 234–236. 1 indexed citations
10.
Brand, Christopher. (2014). Baseline characteristics of over 10,000 patients enrolled into the LUMINOUS study. Investigative Ophthalmology & Visual Science. 55(13). 3061–3061. 1 indexed citations
11.
Brand, Christopher. (2013). LUMINOUS: baseline characteristics of the first cohort of patients treated with ranibizumab 0.5 mg in routine clinical practice. Investigative Ophthalmology & Visual Science. 54(15). 3831–3831. 1 indexed citations
12.
Brand, Christopher. (2012). Management of retinal vascular diseases: a patient-centric approach. Eye. 26(S2). S1–S16. 65 indexed citations
13.
14.
Squirrell, David, et al.. (2010). VISUAL OUTCOME AFTER INTRAVITREAL RANIBIZUMAB FOR WET AGE-RELATED MACULAR DEGENERATION. Retina. 30(3). 436–442. 25 indexed citations
15.
Squirrell, David, et al.. (2009). To investigate the prevalence of polypoidal choroidal vasculopathy in presumed age‐related peripapillary subretinal neovascular membranes. Clinical and Experimental Ophthalmology. 37(4). 368–372. 6 indexed citations
17.
Espallargues, Mireia, Carolyn Czoski‐Murray, Nick Bansback, et al.. (2005). The Impact of Age-Related Macular Degeneration on Health Status Utility Values. Investigative Ophthalmology & Visual Science. 46(11). 4016–4016. 127 indexed citations
18.
Sisley, Karen, Christopher Brand, M A Parsons, et al.. (1998). Cytogenetics of Iris Melanomas: Disparity with Other Uveal Tract Melanomas. Cancer Genetics and Cytogenetics. 101(2). 128–133. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026